nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

03.05.2015 | Original Article

A web-based interactive lifestyle modification program improves lipid profile and serum adiponectin concentrations in patients with metabolic syndrome: the “Red Ruby” study

verfasst von: Mahdieh Abbasalizad Farhangi, Leila Jahangiry, Mir-Mousa Mirinazhad, Davoud Shojaeezade, Ali Montazeri, Alireza Yaghoubi

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The effectiveness of internet-based programs in prevention and treatment of metabolic syndrome has not been fully explored. In the present study, we investigate the effect of a 6-month web-based interactive lifestyle modification program on anthropometric variables and biochemical risk factors of cardiovascular disease. The study had been carried out among 160 patients with metabolic syndrome (intervention, n = 80; control, n = 80). The primary outcomes were change in anthropometric variables, fasting serum glucose (FSG), lipid profile, insulin sensitivity, and serum adiponectin concentrations in intervention and control groups. Significant reductions in anthropometric variables and serum lipids were observed in both intervention and control groups; however, reduction in waist-to-hip ratio (WHR), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) was only significant in intervention group (P < 0.05). Reduction in anthropometric variables and serum triglyceride, systolic and diastolic blood pressure, and liver enzymes were significant in intervention and control groups (P < 0.05) but in women decrease in FSG, TC, and LDL-C were only significant in intervention group (P < 0.05). The present study showed that a web-based intervention was effective in weight loss and improving cardio-metabolic factors in patients with metabolic syndrome after a 6-month intervention.

Aggarwal A, Aggarwal S, Sharma V. Cardiovascular risk factors in young patients of coronary artery disease: differences over a decade. J Cardiovasc Thorac Res. 2014;6(3):169–73.CrossRefPubMedPubMedCentral

Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S, Sadein B. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. HPP. 2013;3(2):206–16.PubMedPubMedCentral

Malik S, Wong ND, Franklin SF, Kamath TV, L’Italien GJ, Pio JR, et al. Cardiovascular disease and all causes in United States adults impact of the metabolic syndrome on mortality from coronary heart disease. Circulation. 2004;110:1245–50.CrossRefPubMed

Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16.CrossRefPubMed

Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.CrossRefPubMed

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287(3):356–9.CrossRefPubMed

Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diab Res Clin Pract. 2003;61(1):29–37.CrossRef

Aggarwal A, Aggarwal S, Sarkar PG, Sharma V. Predisposing factors to premature coronary artery disease in young (age ≤ 45 years) smokers: a single center retrospective case control study from India. J Cardiovasc Thorac Res. 2014;6(1):15–9.PubMedPubMedCentral

Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292(12):1440–6.CrossRefPubMed

10.

Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan (DASH) on features of the metabolic syndrome. Diab Care. 2005;28(12):2823–31.CrossRef

11.

Barry VB, Raiff BR. Weight management preferences in a non-treatment seeking sample. HPP. 2013;3(2):147–53.PubMedPubMedCentral

12.

Bond GE, Burr R, Wolf FM, Price M, Mccurry SM, Teri L. The effects of a web-based intervention on the physical outcomes associated with diabetes among adults age 60 and older: a randomized trial. Diab Technol Ther. 2007;9(1):52–9.CrossRef

13.

Ramadas A, Quek KF, Chan CK, Oldenburg B. Web-based interventions for the management of type 2 diabetes mellitus: a systematic review of recent evidence. Int J Med Inform. 2011;80(6):389–405.CrossRefPubMed

14.

Wantland DJ, Portillo CJ, Holzemer WL, Slaughter R, Mcghee EM. The effectiveness of web-based vs. non-web-based interventions: a meta-analysis of behavioral change outcomes. J Med Internet Res. 2004;6(4):e 40.CrossRef

15.

Tate DF, Jackvony EH, Wing RR. Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes. JAMA. 2003;289(14):1833–6.CrossRefPubMed

16.

McKay HG, King D, Eakin EG, Seeley JR, Glasgow RE. The diabetes network Internet-based physical activity intervention: a randomized pilot study. Diab Care. 2001;24(8):1328–34.CrossRef

17.

Christensen H, Griffiths KM, Jorm AF. Delivering interventions for depression by using the Internet: randomized controlled trial. BMJ. 2004;328:265–8.CrossRefPubMedPubMedCentral

18.

Van-Straten A, Cuijpers P, Smits N. Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trial. J Med Internet Res. 2008;10(1):e7.CrossRefPubMedPubMedCentral

19.

Ybarra ML, Bull SS. Current trends in Internet-and cell phone-based HIV prevention and intervention programs. Curr HIV/AIDS Rep. 2007;4(4):201–7.CrossRefPubMed

20.

Jahangiry L, Shojaeizadeh D, Najafi M, Mohammad K, Abbasalizad Farhangi M, Montazeri A. ”Red Ruby”: an interactive web-based intervention for lifestyle modification on metabolic syndrome: a study protocol for a randomized controlled trial. BMC Public Health. 2014;14:748–56.CrossRefPubMedPubMedCentral

21.

Grundy SM, Hansen B, Smith SC, Cleeman J, Richard A. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109:551–6.CrossRefPubMed

22.

Delavari A, Forouzanfar MH, Alikhani S, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cut-off points of waist circumference in the Middle East: the national survey of risk factors for non-communicable disease of Iran. Diab Care. 2009;32:1092–7.CrossRef

23.

Esteghamati A, Abbasi M, Rashidi A, Meysamie A, Khalilzadeh O, Haghazali M, et al. Optimal waist circumference cut-offs for the diagnosis of metabolic syndrome in adults: results from the third national survey of risk factors of non-communicable disease (SuRFNCD). Diab Med. 2009;26:745–6.CrossRef

24.

Heart N. Lung, and blood institute, obesity education initiative expert panel. Clinical guidelines in identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6(suppl):S51–S210.

25.

Hamwi GL. Changing dietary concepts in diabetes mellitus: diagnosis and treatment. New York: American Diabetes Association; 1964.

26.

Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Diabet Med. 2006;23:469–80.CrossRefPubMed

27.

Farhangi MA, Keshavarz SA, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi AA. White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J Health Popul Nutr. 2013;31:58–64.CrossRefPubMedPubMedCentral

28.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–19.CrossRefPubMed

29.

Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10–4.CrossRefPubMedPubMedCentral

30.

Oh EG, Bang SY, Kim SH, Chu SH, Jeon JY, Im JA, et al. Effects of a 6-month lifestyle modification intervention on the cardiometabolic risk factors and health-related qualities of life in women with metabolic syndrome. Metab Clin Exp. 2010;59(7):1035–43.CrossRefPubMed

31.

Matsuo T, Kim MK, Murotake Y, Numao S, Kim MJ, Ohkubo H, et al. Indirect lifestyle intervention through wives improves metabolic syndrome components in men. Int J Obes. 2009;34(1):136–45.CrossRef

32.

Mcmahon GT, Gomes HE, Hickson HS, Hu TM, Levine BA, Conlin PR. Web-based care management in patients with poorly controlled diabetes. Diab Care. 2005;28:1624–9.CrossRef

33.

Izquierdo RE, Knudson PE, Meyer S, Kearns J, Ploutzsnyder R, Weinstock RS. A comparison of diabetes education administered through telemedicine versus in person. Diab Care. 2003;26:1002–7.CrossRef

34.

Moore TJ, Alsabeeh N, Apovian CM, Murphy MC, Coffman GA, Cullum-Dugan D. Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study. J Med Internet Res. 2008;10(4):e 52.CrossRef

35.

Oenema A, Brug J, Lechner L. Web-based tailored nutrition education: results of a randomized controlled trial. Health Educ Res. 2001;16(6):647–60.CrossRefPubMed

36.

Gold BC, Burke S, Pintauro S, Buzzell P, Harveya- Berino J. Weight loss on the web: a pilot study comparing a structured behavioral intervention to a commercial program. Obesity. 2007;15(1):155–64.CrossRefPubMed

37.

Jackson LA, Ervin KS, Gardner PD, Schmitt N. Gender and the Internet: women communicating and men searching. Sex Roles. 2001;44(5/6):363–79.CrossRef

38.

Mirinazhad MM, Farhangi MA, Jahangiri L, Yaghoubi A. Serum adiponectin concentrations in relation to lipid profile, anthropometric variables and insulin resistance in patients with metabolic syndrome. Mal J Nutr. 2014;20(3):283–9.

39.

Feizollahzadeh S, Rasuli J, Kheirouri S, Alizadeh M. Augmented plasma adiponectin after prolonged fasting during Ramadan in men. HPP. 2014;4(1):77–81.PubMedPubMedCentral

Titel: A web-based interactive lifestyle modification program improves lipid profile and serum adiponectin concentrations in patients with metabolic syndrome: the “Red Ruby” study
verfasst von: Mahdieh Abbasalizad Farhangi
Leila Jahangiry
Mir-Mousa Mirinazhad
Davoud Shojaeezade
Ali Montazeri
Alireza Yaghoubi
Publikationsdatum: 03.05.2015
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 1/2017
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-015-0395-z

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Frequency of MRSA in diabetic foot infections

Effect of bedtime melatonin consumption on diabetes control and lipid profile

Celiac crisis in an adult type 1 diabetes mellitus patient presented with diarrhea, weight loss and hypoglycemic attacks

The efficacy of topical phenytoin in the healing of diabetic foot ulcers: a randomized double-blinded trial

Melatonin: the sleeping hormone

Individuals with diabetes are at a higher risk of asthma in India: evidence from the National Family Health Survey-3